The myth of restenosis after carotid angioplasty and stenting

Winner of the DePuy Synthes Cerebrovascular Section Resident/Fellow Award, Karam Moon, MD, will be presenting his research, The Myth of Restenosis after Carotid Angioplasty and Stenting.

Carotid endarterectomy and stenting was shown to have similar safety and efficacy in the Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis Trial (CREST). Restenosis rates after endovascular treatment are highly variable in the literature and for this pathology are poorly understood.

The study's authors reviewed all patients undergoing (CAS) between 1995 and 2010. Symptomatic and were selected based on North American Symptomatic Carotid Endarterectomy Trial (NASCET) and Asymptomatic Carotid Atherosclerosis Study (ACAS) criteria. Risk factors, indications, rates of technical success, intraoperative and perioperative complications, restenosis (>50 percent) rate and clinical outcomes were evaluated.

A total of 156 patients met inclusion criteria, but 35 were lost to follow-up, leaving 121 patients with 133 vessels treated. Ninety-one (68.4 percent) lesions were symptomatic. Indications for stent placement included patients who were poor surgical candidates, prior endarterectomy, prior radiation, study randomization, acute occlusions, tandem stenosis, high bifurcation and contralateral laryngeal nerve palsy.

Procedures were technically successful in all but one case. Intraoperative and peri-operative stroke occurred in four patients (3 percent). Mean follow-up was 38 months (range one to 204 months). Patients with a prior history of or neck irradiation (hostile-neck) (n=57) comprised 42.9 percent of all vessels treated and were responsible for 15 of 23 restenosis cases, resulting in a significantly higher restenosis rate when compared with primary atherosclerosis lesions (26.3 percent vs. 10.5 percent, P=.017). Five patients (3.8 percent) with restenosis were symptomatic, four of whom were part of the hostile-neck group.

Rates of in-stent restenosis after carotid angioplasty and stenting are low, but differ between patients with atherosclerotic and hostile-neck etiologies. In this large modern series of stenting at a high-volume institution, nearly half of lesions treated were hostile-neck carotids, a cohort that is at higher risk for substantial radiographic and symptomatic restenosis. Counseling for undergoing CAS should reflect the differences between these distinct pathologies.

Explore further

Mortality risks after carotid artery stenting in medicare beneficiaries

Provided by American Association of Neurological Surgeons
Citation: The myth of restenosis after carotid angioplasty and stenting (2015, May 11) retrieved 23 October 2020 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments